• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 144-158 of 180 results

2034 Exhibit: Ex 2034 US 8087562 Knodel

Document IPR2020-00152, No. 2034 Exhibit - Ex 2034 US 8087562 Knodel (P.T.A.B. Jul. 22, 2020)
Lim, Jonas J., et al., “Application of Type Synthesis Theory to the Redesign of a Complex Surgical Instrument”, Journal of Biomechanical Engineering (124), (Jun.
When the surgical stapler 2 clamps tissue that is sufficiently thick and/or tough,the distal end of the anvil 6 may not close completely relative to the staple holder 4.
Somesurgicalstaplers 2 utilize an “l-beam” mechanism, where the upper and lower portions ofthe I-beam eachslide in a corresponding channelinthe staple holder 4 andanvil 6.
However, the I-beam takes up spacein the surgical stapler 2, limits cutting and stapling operations to being performed by motion in the distal direction, and adds to the part count.
They should not and cannot be construed to have any substantive significance, meaning or interpretation, and should not and cannot be deemedto indi- cate that all of the informationrelating to any particular topic is to be found under or limited to any particular heading or subheading.
cite Cite Document

2005 Exhibit: Ex 2005 IPR2019 00880 Depo Transcript of Dr Bryan Knodel 121319

Document IPR2020-00152, No. 2005 Exhibit - Ex 2005 IPR2019 00880 Depo Transcript of Dr Bryan Knodel 121319 (P.T.A.B. Jul. 22, 2020)
(cid:37)(cid:85)(cid:92)(cid:68)(cid:81)(cid:3)(cid:46)(cid:81)(cid:82)(cid:71)(cid:72)(cid:79)(cid:15)(cid:3)(cid:51)(cid:75)(cid:17)(cid:39)(cid:17)(cid:3)(cid:16)(cid:3)(cid:39)(cid:72)
cite Cite Document

2019 Exhibit: Ex 2019 Quality System Regulation, Medical Device GMP FDA

Document IPR2020-00152, No. 2019 Exhibit - Ex 2019 Quality System Regulation, Medical Device GMP FDA (P.T.A.B. Jul. 22, 2020)
The quality systems for FDA-regulated products (food, drugs, biologics, and devices) are known as current good manufacturing practices (CGMP’s).
Under section 520(f) of the act, FDA issued a final rule in the Federal Register of July 21, 1978 (43 FR 31 508), prescribing CGMP requirements for medical devices.
In 1990, FDA undertook the start of the revision of the CGMP regulation to add the design controls authorized by the Safe Medical Devices Act.
It is left to manufacturers to determine the necessity for, or extent of, some quality elements and to develop and implement specific procedures tailored to their particular processes and devices.
These devices are exempted by FDA classification regulations published in the Federal Register and codified in 21 CFR 862 to 892.
cite Cite Document

2035 Exhibit: Ex 2035 EU Council Directive 93 42 EEC

Document IPR2020-00152, No. 2035 Exhibit - Ex 2035 EU Council Directive 93 42 EEC (P.T.A.B. Jul. 22, 2020)
93 Official Journal of the European Communities usefulness of the substances must be verified by analogy with the appropriate methods specified in Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of the MemberStates relating to analytical, pharmaco-toxicological and clinical standards and protocols.
in respect of the testing of proprietary medicinal products('); other and requirements essential the Whereas requirements set out in the Annexes to this Directive, including any reference to ‘minimizing’ or ‘reducing’ risk must be interpreted and applied in such a wayas to take accountof technology and practice existing at the time of design and of technical and economical considerations compatible with a high level of protection of health and safety; in accordance with the principles set out in Whereas, the Council resolution of 7 May 1985 concerning a new approach to technical harmonization and standardization (7), rules regarding the design and .
competent authorities may authorize, on duly justified request, the placing on the market and putting into service, within the territory of the Member State -4,|The Commissionshall, no later than five years from concerned,of individual devices for which the procedures the date of implementation of this Directive, submit a referred to in paragraphs 1 to 6 have not been carried report to the Council on the operation of the provisions out and the use of which is in the interest of protection referred to in Article 10 (1), Article 15 (1), in particular of health, in respect of Class I and Class Ila devices, and on the operation of the.
In the case of devices other than those referred to in the second paragraph, Member States may authorize ‘manufacturers to commence clinical investigations, immediately after the date of notification, provided that the ethics committee concerned has delivered
In the case of devices which have been subjected to EEC pattern approval in accordance with Directive 76/764/EEC, Member States shall accept their being placed on the market and put into service during the period up to 30 June 2004.
cite Cite Document

1027 Exhibit: Petitioners Demonstratives

Document IPR2020-00152, No. 1027 Exhibit - Petitioners Demonstratives (P.T.A.B. Jan. 26, 2021)

cite Cite Document

1022 Exhibit: US Pat No 7,000,818 Shelton 818

Document IPR2020-00152, No. 1022 Exhibit - US Pat No 7,000,818 Shelton 818 (P.T.A.B. Oct. 28, 2020)
Burlington, KY (US); Brian J. Hemmelgarn, Kettering, OH (US) (73) Assignee: Ethicon, Endo-Surger, Inc., Concinnati, OH (US) (*) Notice: Subject to any disclaimer,the term ofthis patent is extended or adjusted under 35 U.S.C. 154(b) by 0 days.
FIG. 17 depicts a side elevation section view of the surgical stapling and severing instrument of FIG. 1 taken along the longitudinal centerline of the end effector in a partially closed but unclamped position gripping tissue.
FIG. 19 depicts a side elevation view in centerline section of the distal end of the surgical stapling and severing instrument of FIG. 1 in the closed or clamped position with tissue properly compressed.
The handle portion 20 includes a pistol grip 24 toward which a closure trigger 26 is pivotally drawn bythe clinician ta cause clamping, or closing,of the anvil 18 toward the clongate channel 16 ofthe end effector 12.
With reference to FIGS. 18-19, next, the clinician moves the closure trigger 26 proximally until positioned directly adjacent to the pistol grip 24, locking the handle portion 20 into the closed and clampedposition.
cite Cite Document

1025 Exhibit: Supplemental Declaration of Dr Bryan Knodel Knodel Supp

Document IPR2020-00152, No. 1025 Exhibit - Supplemental Declaration of Dr Bryan Knodel Knodel Supp (P.T.A.B. Oct. 28, 2020)
If, however, a POSITA used a longer anvil and/or a lightweight material having a thickness that is not sufficient to withstand the clamping and firing forces, then an I-beam (or a similar structure) would have been required to stabilize and align the jaws.
Like Green-209’s slot 260 and pin 262, Green 695’s pivot bar Proceeding No. IPR2020-00152 Attorney Docket No. 11030-0060IP1 24 and notches 28 (as well as locking handle 26 and lugs 21) prevent longitudinal motion of the jaws during firing.
Thus, in context, it is clear that I believe it became mandatory by 2005 (more than four years after the alleged priority date of the ’650 patent) to add a backup manual retraction mechanism to a spring return.
Specifically, Rex Medical argues that the proposed modifications must result in a smaller interior space for capturing diseased tissue or a larger end effector.
The potential for friction and jamming is inherent in any surgical stapler design, but, as previously explained, the prior art confirms that it was a problem a POSITA would have understood how to solve.
cite Cite Document

1017 Exhibit: US Pat No 5,445,644 Pietrafitta

Document IPR2020-00152, No. 1017 Exhibit - US Pat No 5,445,644 Pietrafitta (P.T.A.B. Oct. 28, 2020)
FIG.3 is a side view of a pyloroplasty/pylorectomy Another deficiency associated with conventional shield of the prior art mounted to the cartridge of a pyloroplasty/pylorectomyshields relates to the length circular stapler having an embodiment of a conven- tional anvil.
pylorectomy shield of the present invention inserted Yet another deficiency associated with the conven- through a trocar into the stomach of a mammal and tional pyloroplasty/pylorectomyshields used with con- positioned in the pylorus prior to performing a pyloro- ventional circularstaplersis that, typically, a relatively plasty/pylorectomy.
large diameter stapler must be used to perform the ana- FIG.9 is a side view of the pyloroplasty/pylorec- stomosis thereby aggravating the traumatic effects of tomy shield of the present invention andastaple car- pyloric dilation.
Typically, the patient is then insuf- flated with a sterile gas such as carbon dioxide in order to inflate the body cavity to give the surgeon room to maneuver the instruments.
An- other major deficiency of the pyloroplasty/pylorec- tomyshield 280 is that becauseit is configured to extend distally from the cartridge 265 of the stapler 250, it is possible for the shield member 287to pierce or tear the stomach lining, the pylorus or the duodenum during insertion.
cite Cite Document

1026 Exhibit: Deposition transcript of Albert Juergens October 1, 2020

Document IPR2020-00152, No. 1026 Exhibit - Deposition transcript of Albert Juergens October 1, 2020 (P.T.A.B. Oct. 28, 2020)

cite Cite Document

1020 Exhibit: US Pat No 5,485,947 Olson

Document IPR2020-00152, No. 1020 Exhibit - US Pat No 5,485,947 Olson (P.T.A.B. Oct. 28, 2020)

cite Cite Document

2003 Exhibit: Ex 2003 Claim Construction Order, Rex Medical v Intuitive 5520

Document IPR2020-00152, No. 2003 Exhibit - Ex 2003 Claim Construction Order, Rex Medical v Intuitive 5520 (P.T.A.B. Jul. 22, 2020)

cite Cite Document

2004 Exhibit: Ex 2004 Depo Transcript of Dr Bryan Knodel 63020

Document IPR2020-00152, No. 2004 Exhibit - Ex 2004 Depo Transcript of Dr Bryan Knodel 63020 (P.T.A.B. Jul. 22, 2020)

cite Cite Document

2038 Exhibit: Ex 2038 IPR2019 00880 Supp Depo Transcript of Dr Bryan Knodel 5 ...

Document IPR2020-00152, No. 2038 Exhibit - Ex 2038 IPR2019 00880 Supp Depo Transcript of Dr Bryan Knodel 5 14 20 (P.T.A.B. Jul. 22, 2020)

cite Cite Document

2020 Exhibit: Ex 2020 4 Key Compliance Issues for Medical Device Companies

Document IPR2020-00152, No. 2020 Exhibit - Ex 2020 4 Key Compliance Issues for Medical Device Companies (P.T.A.B. Jul. 22, 2020)

cite Cite Document

2006 Exhibit: Ex 2006 IPR2019 00880 Decl of Dr Bryan Knodel

Document IPR2020-00152, No. 2006 Exhibit - Ex 2006 IPR2019 00880 Decl of Dr Bryan Knodel (P.T.A.B. Jul. 22, 2020)

cite Cite Document
<< 1 2 3 4 5 ... 10 11 12 13 >>